Remove enveric-biosciences-updates-key-data-underpinning-selection-of-eb-003-as-lead-drug-candidate-from-evm301-series
article thumbnail

Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series

Medical Marijuana Program Connection

.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today provided an update on data underpinning the selection of EB-003 as its lead (..)

Data 64